Study analyzing 27 genes that increase susceptibility to hereditary cancer.
850,00 €
Study analyzing 27 genes that increase susceptibility to hereditary cancer.
The hereditary cancer panel is a study that analyzes 27 genes that increase the susceptibility to hereditary cancer. This susceptibility is transmitted among family members according to different inheritance patterns.
The greater and better knowledge of the genetic and molecular basis of cancer, as well as new and increasingly sensitive imaging and laboratory techniques, allow for preventive medicine, capable of identifying individuals at high risk of developing certain types of tumors and improving long-term prognosis.
The panel developed by Cerba includes a total of 27 genes with implications in the development of hereditary breast and ovarian cancer, but also prostate, pancreatic and melanoma.
Through genetic counseling, patients with hereditary predisposition to cancer receive information on:
Indicated for women and men with a personal or family history of cancer.
DELIVERY TIME: 45 WORKING DAYS.
Extraction of 5 mL of EDTA blood.
Receipt and analysis of the sample in our laboratory.
Sending of the report in 45 working days.
For further clarification, your doctor will explain the results.
A bibliography is also included with the bibliographic references of the programs used, as well as in the case of pathogenic/VOUS results, the references that support the interpretations of the results obtained in case they are described.
Choose to take care of yourself.
Pay safely.
Go to a Cerba center.
Check your results online.